Anne Reiser - ResMed Insider

RMD -- USA Stock  

USD 108.26  1.53  1.43%

Ms. Anne Reiser is President Europe Asia Pacific of Resmed Inc. Ms. Reiser was appointed president of our Europe and Asia Pacific region in December 2014. Previously, Ms. Reiser was president of ResMeds Europe region, a position she began in March 2012. She served as our chief operating officer France beginning in 2007, after joining as the sales director in 2006. Before joining ResMed, her career experience was in the medical device industry . More recently she worked for Medtronic and Hollister, with responsibilities for both France and finally southern European countries
Age: 54  President Since 2014      
Reiser has a master degree from Ecole Sup?rieure de Commerce de ClermontFd, and a bachelor degree of law from the University of ClermontFerrand and an executive master in management and healthcare policies from SciencesPo Paris.

Anne Reiser Latest Insider Activity

Management Efficiency

The company has Return on Asset of 10.72 % which means that on every $100 spent on asset it made $10.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.7 % implying that it generated $15.7 on every 100 dollars invested.
The company has 281.45 M in debt with debt to equity (D/E) ratio of 13.6 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 2.05 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Shari OQuinnEndologix
Michael MaszyEndologix
Sandra JesseHaemonetics Corporation
Bernard KahlertCantel Medical Corp
Richard WagnerHill Rom Holdings
Byron SelmanHaemonetics Corporation
Dottie DonnellyBrienzaCantel Medical Corp
Francisco VegaHill Rom Holdings
Russ AngoldEkso Bionics Holdings
Jerome HurwitzBecton Dickinson and Company
Timothy LawrenceHill Rom Holdings
David WilsonHaemonetics Corporation
Michiel ZwaanHill Rom Holdings
James MachekEndologix
Jeffrey ShermanBecton Dickinson and Company
Kevin McCullochHill Rom Holdings
Jason RichardsonHill Rom Holdings
Meredith HuetterEndologix
Thomas McCurdyHaemonetics Corporation
Holly SheffieldThe Cooper Companies
Carlos MarumHill Rom Holdings

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on BATS Exchange. It employs 6000 people.ResMed (RMD) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 6,000 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.

ResMed Leadership Team

John Wareham, Independent Director
Ronald Taylor, Lead Independent Director
Rob Douglas, President COO
Christopher Roberts, Independent Director
Gary Pace, Independent Director
Chris Roberts, Independent Director
Robert Douglas, Pres and COO
Agnes Lee, Senior Director - Investor Relations
Carol Burt, Independent Director
Rich Sulpizio, Independent Director
Peter Farrell, Non-Executive Chairman of the Board
Jim Hollingshead, President - Americas
Brett Sandercock, CFO and Principal Accounting Officer
Ron Taylor, Lead Independent Director
Don Darkin, President - Sleep-disordered Breathing Strategic Business Unit
Jack Wareham, Independent Director
Anne Reiser, President Europe
Karen Drexler, Director
Raj Sodhi, President ? Software as a Service (SaaS) Business and CTO
David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary
Richard Sulpizio, Independent Director
Michael Farrell, CEO and Director
Richard McHale, President ? Respiratory Care
Donald Darkin, President ? innovation & operations

Stock Performance Indicators

Current Sentiment - RMD

ResMed Investor Sentiment
Greater number of Macroaxis users are at this time bullish on ResMed. What is your perspective on investing in ResMed? Are you bullish or bearish?
98% Bullish
2% Bearish
Currently Active Assets on Macroaxis
Purchased over 500 shares of
few days ago
Traded for 6.08
Purchased over 500 shares of
few days ago
Traded for 6.08
Purchased over 100 shares of
few days ago
Traded for 2.17
Purchased over 40 shares of
few days ago
Traded for 71.99
Purchased over 300 shares of
few days ago
Traded for 9.91
Additionally take a look at Your Equity Center. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.